WVE Q2 2019 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+56.3% YoY

Gross Profit

-$34M-445.4% margin

Operating Income

-$46M-598.0% margin

Net Income

-$42M-549.8% margin

EPS (Diluted)

$-1.22

QoQ Revenue Growth

+152.1%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$35M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$386M

Total Liabilities

$225M

Stockholders' Equity

$160M

Cash & Equivalents

$253M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+56.3%
Gross Profit	-$34M	-$28M	-22.8%
Operating Income	-$46M	-$37M	-24.7%
Net Income	-$42M	-$36M	-16.8%